<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00864955</url>
  </required_header>
  <id_info>
    <org_study_id>DCIC 08 13</org_study_id>
    <nct_id>NCT00864955</nct_id>
  </id_info>
  <brief_title>Cutaneous DNA Damage Caused by UV-A Irradiation</brief_title>
  <acronym>DIMUVA</acronym>
  <official_title>Damage to DNA Caused by UV-A Irradiation: Photochemical Mechanism and Cutaneous Parameters Involved in the Formation of Cyclobutane Pyrimidine Dimers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Commissariat A L'Energie Atomique Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The DIMUVA study aims to evaluate the correlation between cutaneous phototype and the nature
      and quantity of damage caused to cutaneous DNA after exposure to UV-A radiation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Due to their capacity to damage Deoxyribonucleic acid (DNA), Ultra-Violet (UV) radiation is
      one of the causes of skin cancers.

      Until recently, the genotoxic effects of UV-A radiation, were poorly identified, in
      particular their capacity to lead to the dimerization of pyrimidine bases .

      It is well known that the response to UV-A and UV-B radiations is different depending on the
      cutaneous phototype.

      Thus, the aim of this study is to determine the correlation between cutaneous phototype and
      the quantity and nature (CPD or oxidative lesions) of damage caused to cutaneous DNA after an
      ex-vivo exposure to UV-A and UV-B radiations.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Phototype determination according to the Fitzpatrick classification Number of CPD and oxidative lesions determinated by the analysis of DNA from the skin biopsies after their ex-vivo exposure to UV-A - The CPD / Oxidative lesions ratio</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of CPD and oxidative lesions determinated by the analysis of DNA from the skin biopsies after their exposure ex-vivo to UV-B.</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UV-A radiation exposure: Minimal erythemic dose - Number of CPD and oxidative lesions - CPD / oxidative lesions ratio</measure>
    <time_frame>Day x</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UV-B radiation exposure: Minimal erythemic dose - Number of CPD and oxidative lesions - CPD/oxidative lesions ratio</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>antioxidant status and quantity of CPD, oxidative lesions after exposure to UV-A and UV-B radiations</measure>
    <time_frame>day 2</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>phototype 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Volunteers with cutaneous phototype 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>phototype 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Volunteers with cutaneous phototype 4</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>UVA and UVB irradiation</intervention_name>
    <description>4 cutaneous biopsies for Ex-vivo irradiation
Determination of the minimal erythemic dose of UVA and UVB for each volunteer</description>
    <arm_group_label>phototype 2</arm_group_label>
    <arm_group_label>phototype 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male,

          -  Between 18 and 35 years old,

          -  Healthy volunteers,

          -  Cutaneous phototype 2 or 4 according to the Fitzpatrick classification,

          -  Affiliation to the French Social Security.

        Exclusion Criteria:

          -  History of photosensibility,

          -  Active smoking or stopped since less than one year,

          -  Dermatological pathology or treatment contra-indicating cutaneous irradiation and skin
             biopsies,

          -  Any chronic pathology susceptible to interfere with the evaluations related to the
             protocol,

          -  Allergy to local anaesthetics,

          -  Volunteers who take drugs and/or food complements acting on oxidative stress in the 8
             weeks preceding inclusion,

          -  Volunteers who have take paracetamol or aspirin within 7 days prior to the inclusion
             visit,

          -  Subject in exclusion period for another biomedical research study,

          -  Subject having exceeded the threshold of annual compensation for biomedical research.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Claude BEANI, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre d'investigation Clinique ,University Hospital Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Dermatology, University Hospital Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Brash DE. Sunlight and the onset of skin cancer. Trends Genet. 1997 Oct;13(10):410-4. Review.</citation>
    <PMID>9351343</PMID>
  </reference>
  <reference>
    <citation>Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res. 2005 Apr 1;571(1-2):91-106. Review.</citation>
    <PMID>15748641</PMID>
  </reference>
  <reference>
    <citation>Cadet J, Sage E, Douki T. Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res. 2005 Apr 1;571(1-2):3-17. Epub 2005 Jan 26. Review.</citation>
    <PMID>15748634</PMID>
  </reference>
  <reference>
    <citation>Douki T, Reynaud-Angelin A, Cadet J, Sage E. Bipyrimidine photoproducts rather than oxidative lesions are the main type of DNA damage involved in the genotoxic effect of solar UVA radiation. Biochemistry. 2003 Aug 5;42(30):9221-6.</citation>
    <PMID>12885257</PMID>
  </reference>
  <reference>
    <citation>Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10529-33.</citation>
    <PMID>8248141</PMID>
  </reference>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2009</study_first_submitted>
  <study_first_submitted_qc>March 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2009</study_first_posted>
  <last_update_submitted>September 2, 2009</last_update_submitted>
  <last_update_submitted_qc>September 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Direction de la Recherche Clinique</name_title>
    <organization>University Hospital Grenoble</organization>
  </responsible_party>
  <keyword>UV-A irradiation</keyword>
  <keyword>Cyclobutane-Pyrimidine Dimer</keyword>
  <keyword>Oxidative lesions</keyword>
  <keyword>cutaneous phototype</keyword>
  <keyword>UV-B irradiation</keyword>
  <keyword>DNA damages</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

